Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes
Author(s) -
Suetonia C. Palmer,
Dimitris Mavridis,
Antonio Nicolucci,
David W. Johnson,
Marcello Tonelli,
Jonathan C. Craig,
Jasjot Maggo,
Vanessa Gray,
Giorgia De Berardis,
Marinella Ruospo,
Patrizia Natale,
Valeria Saglimbene,
Sunil V. Badve,
Yeoungjee Cho,
AnnieClaire NadeauFredette,
Michael Burke,
Labib Imran Faruque,
Anita Lloyd,
Nasreen Ahmad,
Yuanchen Liu,
Sophanny Tiv,
Natasha Wiebe,
Giovanni FM Strippoli
Publication year - 2016
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2016.9400
Subject(s) - medicine , metformin , type 2 diabetes , adverse effect , sulfonylurea , odds ratio , hypoglycemia , diabetes mellitus , randomized controlled trial , insulin , endocrinology
Numerous glucose-lowering drugs are used to treat type 2 diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom